PagerDuty (PD) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its earnings outlook is still improving.The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this software developer, should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revis ...

Investors might want to bet on Prestige Consumer Healthcare (PBH) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years. ...

Steris (STE) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.The power of a changing earnin ...

Investors might want to bet on Stagwell (STGW) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.Since a chan ...

First Industrial Realty Trust (FR) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Individ ...

Atmos Energy (ATO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Since a changing earning ...

Shares of PagerDuty (PD) have gained 12% over the past four weeks to close the last trading session at $13.04, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $16.75 indicates a potential upside of 28.5%.The mean estimate comprises eight short-term price targets with a standard deviation of $2.82. While the lowest estimate of $12.00 indicates a 8% decline from the current price ...

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?Let's take a look at what these Wall Street heavyweights have to say about Ulta Beauty (ULTA) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Ulta currently has an average brokerage ...

公司评级与核心观点 - Actuate Therapeutics, Inc. (ACTU) 的Zacks评级被上调至第2级（买入），这主要反映了其盈利预期的上升趋势，而盈利预期是影响股价最强大的力量之一 [1] - 评级上调本质上是对公司盈利前景的积极评价，可能对其股价产生有利影响 [4] - 将公司评级上调至Zacks第2级，使其在Zacks覆盖的股票中，就盈利预期修正而言位列前20%，这意味着该股可能在短期内走高 [11] 盈利预期修正与股价关系 - 公司未来盈利潜力的变化（反映在盈利预期修正中）与其股价的短期走势已被证明有很强的相关性 [5] - 机构投资者利用盈利和盈利预期来计算公司股票的公平价值，其估值模型中盈利预期的增减直接导致股票公平价值的升降，进而引发其大宗买卖行为并推动股价变动 [5] - 实证研究表明，盈利预期修正趋势与短期股价变动之间存在很强的相关性，跟踪这些修正来做出投资决策可能带来丰厚回报 [7] Zacks评级系统介绍 - Zacks评级系统的核心是公司盈利前景的变化，该系统追踪Zacks共识预期（即卖方分析师对股票每股收益预期的共识度量），涵盖当前及下一财年 [2] - Zacks股票评级系统使用四个与盈利预期相关的因素，将股票分为五组，从Zacks第1级（强力买入）到第5级（强力卖出）[8] - 自1988年以来，Zacks第1级股票的平均年回报率为+25% [8] - Zacks评级系统在任何时间点都为其覆盖的超过4000只股票维持“买入”和“卖出”评级的同等比例，无论市场条件如何，只有排名前5%的股票获得“强力买入”评级，接下来的15%获得“买入”评级 [10] Actuate Therapeutics具体财务预期 - 市场预计该公司在截至2025年12月的财年每股收益为-1.10美元，与去年同期相比没有变化 [9] - 在过去的三个月里，该公司的Zacks共识预期提高了0.9% [9]

文章核心观点 - 文章核心观点为 NextNav Inc (NN) 因其盈利预期被上调 被提升至 Zacks Rank 2 (买入) 评级 这反映了市场对其盈利前景的乐观情绪 并可能推动其股价在短期内上涨 [1][3][10] Zacks评级系统及其原理 - Zacks评级系统的核心是追踪盈利预期的变化 该系统跟踪卖方分析师对个股当前及下一财年每股收益(EPS)预估的共识 即Zacks共识预期 [1] - 该系统利用与盈利预期相关的四个因素 将股票分为五组 从Zacks Rank 1 (强力买入) 到 Zacks Rank 5 (强力卖出) [7] - 该系统在任何时间点对其覆盖的超过4000只股票保持“买入”和“卖出”评级的均等比例 无论市场条件如何 只有排名前5%的股票获得“强力买入”评级 接下来的15%获得“买入”评级 因此进入前20%的股票表明其盈利预期修正特征优异 [9][10] - 历史数据显示 Zacks Rank 1 的股票自1988年以来实现了平均年化+25%的回报 [7] 盈利预期修正与股价的关系 - 公司未来盈利潜力的变化 体现在盈利预期的修正上 已被证明与其股价的短期走势高度相关 [4] - 这种相关性部分源于机构投资者的影响 他们使用盈利及盈利预期来计算公司的公允价值 其估值模型中盈利预期的增减会直接导致股票公允价值的升降 进而引发机构投资者的买卖行为 其大规模投资行动最终推动股价变动 [4] - 实证研究表明 盈利预期修正的趋势与短期股价波动之间存在强相关性 [6] NextNav Inc (Spartacus Acquisition) 的具体情况 - 该公司被升级至 Zacks Rank 2 (买入) 评级 这使其进入Zacks覆盖股票中盈利预期修正表现最好的前20%行列 [10] - 市场预计该公司在截至2025年12月的财年每股收益为 -$1.00 与去年同期相比没有变化 [8] - 然而 分析师一直在稳步上调对该公司的预期 在过去三个月里 该公司的Zacks共识预期提高了29.7% [8] - 盈利预期的上升和随之而来的评级上调 意味着公司基本业务的改善 [5]